Table 5.
Antimicrobial agent | 1993 study (n = 12)a |
2001 study (n = 16)b |
CHIMED study, 2003-2004 (n = 18)c |
|||
---|---|---|---|---|---|---|
MIC50 | MIC90 | Disk (μg/ml) | % sensitivity | MIC50 | MIC90 | |
Ciprofloxacin | 2 | 8 | 2 | 100 | ≤1 | 4 |
Clarithromycin | ≤0.25 | ≤0.25 | 3 | 100 | ≤2 | ≤2 |
Rifabutin | ≤0.03 | ≤0.03 | NT | NT | ≤0.2 | ≤0.2 |
Rifampin | 0.5 | 1 | 1 | 94 | 0.2 | 1 |
Amikacin | 4 | 8 | 2 | 100 | 10 | 20 |
Ethionamide | R* | R* | 5 | 0 | NT | NT |
Streptomycin | NT | NT | 10 | 100 | 10 | 20 |
Ethambutol | R* | R* | 5 | 0 | >20 | >20 |
Isoniazid | 8 | >32 | 0.2 | 0 | ≥20 | ≥20 |
Clofazimine | 2 | 2 | NT | NT | ≤0.5 | ≤0.5 |
Prothionamide | NT | NT | NT | NT | 5 | 20 |
Cycloserine | NT | NT | NT | NT | 50 | >50 |
Data from reference 9. The method applied was a microtiter array with Middlebrook 7H9 broth plus hemin. MICs are in μg/ml.
Data from reference 126. The method applied was a disk elution method on Middlebrook 7H10 agar with hemin.
The method applied was an agar dilution method on Middlebrook 7H10 medium with a hemin source. MICs are in μg/ml.
R*, tested but not active; NT, not tested.